Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(20%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_4

40%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

2(50.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Detailed Status

Completed4

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 42 (50.0%)

N/A2 (50.0%)

Trials by Status

active_not_recruiting120%

completed480%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy

NCT02573766

completednot_applicable

Teleconsultations Hypnosis Sessions for Patients with Peripheral Chronic Neuropathic Pain

NCT05623449

completedphase_4

Clinical Trials (5)

Showing 5 of 5 trials

NCT02573766Not Applicable

Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy

Active Not Recruiting

NCT05623449Not Applicable

Teleconsultations Hypnosis Sessions for Patients with Peripheral Chronic Neuropathic Pain

Completed

NCT04781075Phase 4

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

Completed

NCT02819076

EVENDOL Scale Validation for at Term New-born

Completed

NCT03001843Phase 4

Ketamine vs Hydromorphone

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5